It’s great at manufacturing chips and other hardware, no doubt about that. But that’s all relatively low margin stuff. The profit that TSMC makes on each individual chip is relatively small, but they make a lot of them. Also a lot of the chips they make are actually designed by others…they basically are doing contract manufacturing.
A country waiting to become an IT centre needs to encompass much more than that. Software and services are where the wider opportunities are, and that means lots of software development skills, UI design, knowledge of business process optimisation and management, system security skills and so on. Are there any examples of Taiwanese companies which compete internationally in any of these areas?
Just look at the websites of leading companies in Taiwan. Many still seem to be stuck with an aesthetic from the early 2000s (or even earlier, judging by some bank websites).
I don’t agree that finance is zero sum. There’s a lot more to it that just trading stocks. It brings with it a lot of ancillary services, such as legal, accounting and administration. Additionally, having an active finance industry means it’s also easier for people to raise money for new ventures.
Finance is demanding and attracts high achievers and people with international mindsets. Go to Hong Kong, Singapore, New York (and even London) and you’ll find plenty of Taiwanese working in those financial centres, having left Taiwan because they couldn’t find interesting and challenging work here.
Same with IT…there’s a reason that the likes of Yahoo,Youtube and others were started by Taiwanese in the US rather than in Taiwan. It’s easier to create a startup company, get finance, and basically just take a risk over there.
Singapore and Hong Kong have been improving in these too areas over the past 5-10 years. You can get companies set up within an hour or two, all electronically - you don’t even need to be there physically. There are non-traditional banking options for startups, which you can get opened within a day - without needing any visit to a branch. The processes are very streamlined and improving all the time.
As for biomedical being low margin, Moderna, BNT and Pfizer might disagree with you! The problem with biomedical here is that the Taiwan FDA is painfully conservative. It’s virtually impossible to get approval for anything medical-related here, unless it has already been approved by somewhere else, such as the US FDA or has European CE approval. That means that any local biomedical development hits a brick wall when they want to create a product. In most countries, you develop a new product and first sell it to your domestic market to gain experience, and maybe fine-tune it, and then use that experience to take it international. But if your local agency won’t approve it in the first place, then you’re stuck